144 related articles for article (PubMed ID: 3899669)
1. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
3. Intravenous pinacidil in the acute treatment of hypertension.
Rijk MC; Thien T
J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
[TBL] [Abstract][Full Text] [Related]
4. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Collart F; Staroukine M; Verniory A
Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
6. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
Solomon RJ; Weinberg MS
J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
[TBL] [Abstract][Full Text] [Related]
7. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
Goldberg MR
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
[TBL] [Abstract][Full Text] [Related]
10. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension.
Koenig W; Binner L; Gabrielsen F; Sund M; Rosenthal J; Hombach V
J Cardiovasc Pharmacol; 1991 Sep; 18(3):349-53. PubMed ID: 1720834
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
[TBL] [Abstract][Full Text] [Related]
14. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
Sterndorff B; Johansen P
Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
[TBL] [Abstract][Full Text] [Related]
15. Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.
Breen EG; Mulhall D; Keogh JA
Eur J Clin Pharmacol; 1985; 28(4):381-6. PubMed ID: 4029244
[TBL] [Abstract][Full Text] [Related]
16. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
17. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.
D'Arcy V; Laher M; McCoy D; Sullivan P; Walsh CH; Hickey MP
Eur J Clin Pharmacol; 1985; 28(3):347-9. PubMed ID: 4007040
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
Sterndorff B; Johansen P
Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
[No Abstract] [Full Text] [Related]
20. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
